According to the NICE Clinical Knowledge Summary (CKS) and the British National Formulary (BNF) , the standard treatment for B12 deficiency without neurological symptoms involves: Hydroxocobalamin 1 mg intramuscularly three times weekly for two weeks Followed by maintenance doses of 1 mg every three months For patients with neurological symptoms (such as paraesthesia, numbness, cognitive changes, or gait disturbances), more intensive treatment is required: Hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement occurs Followed by 1 mg every two months for maintenance Pernicious anaemia , an autoimmune condition where the body cannot produce intrinsic factor, requires lifelong treatment
KLOW and GLP-1 medications act through different receptor systems while there is no direct synergy, KLOW can support tissue healing from training and reduce inflammation during GLP-1-induced rapid weight loss
I hope you will update the forum
In simple terms, it is studied for its ability to signal fat cells to release and burn stored fat while leaving blood sugar regulation largely untouched
Some medications, like GLP-1 drugs for obesity, are also peptides